The global Hajdu-Cheney Syndrome (HCS) Treatment Market is characterized by a unique dynamic driven by its extreme rarity (fewer than 100 cases reported) and the lack of a standardized cure. Market growth is sustained by the high cost and resource intensity of managing severe, multi-systemic symptoms, particularly the progressive bone loss and skeletal deformities characteristic of th... https://livepositively.com/unlocking-value-pricing-regulatory-landscape-and-future-forecast-for-the-ocular-bromfenac-market-2025-2032/